Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
   
   

A method is described for inhibiting mitogen activated protein kinase-activated protein kinase-2 in a subject in need of such inhibition, where the method involves administering to the subject a beta-carboline MK-2 inhibiting compound, or a pharmaceutically acceptable salt thereof.

 
Web www.patentalert.com

< Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method

< Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes

> Urea thiadiazole inhibitors of plasminogen activator inhibior-1

> Substituted cyclic amine metalloprotease inhibitors
~ 00189